Found: 26
Select item for more details and to access through your institution.
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy.
- Published in:
- FEBS Letters, 2014, v. 588, n. 2, p. 288, doi. 10.1016/j.febslet.2013.11.030
- By:
- Publication type:
- Article
Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain.
- Published in:
- Human Molecular Genetics, 2013, v. 22, n. 9, p. 1709, doi. 10.1093/hmg/ddt017
- By:
- Publication type:
- Article
Context Fear Conditioning in Down Syndrome Mouse Models: Effects of Trisomic Gene Content, Age, Sex and Genetic Background.
- Published in:
- Genes, 2021, v. 12, n. 10, p. 1528, doi. 10.3390/genes12101528
- By:
- Publication type:
- Article
Meditation as a Potential Therapy for Autism: A Review.
- Published in:
- Autism Research & Treatment, 2012, p. 1, doi. 10.1155/2012/835847
- By:
- Publication type:
- Article
Structural conversion of neurotoxic amyloid-β<sub>1–42</sub> oligomers to fibrils.
- Published in:
- Nature Structural & Molecular Biology, 2010, v. 17, n. 5, p. 561, doi. 10.1038/nsmb.1799
- By:
- Publication type:
- Article
Role of mosaic aneuploidy in the development and progression of Huntington's disease: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047662
- By:
- Publication type:
- Article
P4‐032: GM‐CSF REVERSES MEMORY DEFICITS IN NORMAL AGED MICE AND IN THE DP(16)1YEY MOUSE MODEL OF DOWN SYNDROME.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1286, doi. 10.1016/j.jalz.2019.06.3691
- By:
- Publication type:
- Article
P2‐162: GM‐CSF REVERSES MEMORY DEFICITS IN THE DP16 MOUSE MODEL OF DOWN SYNDROME.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P730, doi. 10.1016/j.jalz.2018.06.849
- By:
- Publication type:
- Article
Structure based refinement of a humanized monoclonal antibody that targets tumor antigen disialoganglioside GD2.
- Published in:
- Frontiers in Immunology, 2014, v. 5, p. 1, doi. 10.3389/fimmu.2014.00372
- By:
- Publication type:
- Article
<i>In silico</i> Driven Redesign of a Clinically Relevant Antibody for the Treatment of GD2 Positive Tumors
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063359
- By:
- Publication type:
- Article
Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners?
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. 1, doi. 10.3389/fnagi.2021.718426
- By:
- Publication type:
- Article
Sex differences in protein expression in the mouse brain and their perturbations in a model of Down syndrome.
- Published in:
- Biology of Sex Differences, 2015, v. 6, p. 1, doi. 10.1186/s13293-015-0043-9
- By:
- Publication type:
- Article
The presence of radioactive and metal contaminants in wild mushrooms grown in Chattogram hill tracts, Bangladesh.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2019, v. 322, n. 1, p. 173, doi. 10.1007/s10967-019-06579-6
- By:
- Publication type:
- Article
Determination of Elemental Composition of Malabar spinach, Lettuce, Spinach, Hyacinth Bean, and Cauliflower Vegetables Using Proton Induced X-Ray Emission Technique at Savar Subdistrict in Bangladesh.
- Published in:
- BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/128256
- By:
- Publication type:
- Article
Structural design of disialoganglioside GD2 and CD3-bispecific antibodies to redirect T cells for tumor therapy.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 2, p. 476, doi. 10.1002/ijc.29007
- By:
- Publication type:
- Article
Altered Protein Profiles During Epileptogenesis in the Pilocarpine Mouse Model of Temporal Lobe Epilepsy.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.654606
- By:
- Publication type:
- Article
Protein Dynamics Associated with Failed and Rescued Learning in the Ts65Dn Mouse Model of Down Syndrome.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0119491
- By:
- Publication type:
- Article
The immune cytokine granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) is an effective treatment for both Alzheimer's disease and the viral diseases caused by West Nile Virus and SARS‐CoV‐2 infection, indicating that inflammation and viral infection may be partners and therapeutic co‐targets in many brain disorders
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.080184
- By:
- Publication type:
- Article
GM‐CSF Treatment Increases the Number of Purkinje Cells in a Mouse Model of Down Syndrome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080088
- By:
- Publication type:
- Article
Alzheimer's disease phenotypes in human induced pluripotent stem cell‐based models of Down syndrome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080065
- By:
- Publication type:
- Article
Increased Expression of Kif11/Kinesin‐5 mRNA Offsets Cognitive Deficits In An Alzheimer's Mouse Model, Blocks Aβ‐Mediated Decreases in Long‐Term Potentiation and Spine Density, and is Associated With Better Cognitive Performance in Alzheimer's Patients
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.068051
- By:
- Publication type:
- Article
Elevated levels of mosaic aneuploidy in brain cells and fibroblast cell lines from human Huntington's disease donors and in brain cells from Huntington's disease mouse models.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.067326
- By:
- Publication type:
- Article
Traumatic Brain Injury Exacerbates Retinal Alzheimer's Disease Histopathology in the TgF344 Rat Model.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 1, doi. 10.1002/alz.068278
- By:
- Publication type:
- Article
Granulocyte‐Macrophage Colony‐Stimulating Factor Reduces Two Major Pathological Hallmarks of Alzheimer's Disease and Astrogliosis in the TgF344‐AD Rat Model.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 3, p. 1, doi. 10.1002/alz.067785
- By:
- Publication type:
- Article
Inflammation and innate immune system activation in neurodegeneration, Down syndrome, aging, and infection: Therapeutic target or partner?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056681
- By:
- Publication type:
- Article
Granulocyte‐macrophage colony‐stimulating factor reverses Alzheimer's disease pathology in the tgf344‐AD rat model.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.056289
- By:
- Publication type:
- Article